James Gillard

Compound Aggregation in Drug Discovery: Implementing a Practical NMR Assay for Medicinal Chemists

Steven R. LaPlante, Rebekah Carson, James Gillard et al. · Journal of Medicinal Chemistry · 2013 · 104 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives

Pierre L. Beaulieu, Michael Bös, Yves Bousquet et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 103 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

Pierre L. Beaulieu, Michael Bös, Yves Bousquet et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Synthesis of (1<i>R</i>,2<i>S</i>)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives:  Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease

Pierre L. Beaulieu, James Gillard, Murray D. Bailey et al. · The Journal of Organic Chemistry · 2005 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Non-Nucleoside Benzimidazole-Based Allosteric Inhibitors of the Hepatitis C Virus NS5B Polymerase:  Inhibition of Subgenomic Hepatitis C Virus RNA Replicons in Huh-7 Cells

Pierre L. Beaulieu, Yves Bousquet, Jean Gauthier et al. · Journal of Medicinal Chemistry · 2004 · 87 citations

Medicine, Medicinal Chemistry, Pharmacology +17